" Lifeist to acquire the fast-growing ‘Zest’ brand

Lifeist Wellness (TSXV:LFST) has signed a share purchase agreement to acquire the Zest brand.

" Best biotech stocks to buy in 2023

Innovation continues to drive the broader healthcare market, and the best biotech stocks are at the forefront of new developments and therapies to

" WELL Health NCIB suggests undervaluation

WELL Health has entered into an automatic share purchase plan to facilitate share repurchases.

" Advancing environmental work at the Frances Creek barium project

Voyageur Pharmaceuticals (TSXV:VM) has finished environmental and geotechnical field work at its Frances Creek project site.

" Psychedelics company begins phase 3 psilocybin study for depression

Psychedelics company Numinus Wellness and subsidiary Cedar Clinical Research have initiated a study on psilocybin therapy.

" Medtech AI is advancing innovations to treat Parkinson’s Disease

EvokAI Creative Labs (TSXV:OKAI) has acquired Finnish MedTech company Head Instruments Oy.

" BioSyent reports Q1 2023 financial results

BioSyent (TSXV:RX) released its financial results for the three months ended March 31, 2023.
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" Highmark Interactive approved for reimbursement services of remote patient monitoring devices

Highmark Interactive (V.HMRK) has been processed for remote patient monitoring and reimbursed by Medicare for those services.

" New data to be highlighted at the world’s top cancer conference

Next week, top health care firms will converge or the biggest cancer conference in the world.

" Kane Biotech attains FDA clearance for its coactiv+ wound gel

Kane Biotech (TSXV:KNE) receives 510(k) clearance of its coactiv+™ antimicrobial wound gel from the U.S.
The Market Herald Video

" Voyageur Pharmaceuticals (TSXV:VM) announces ground-breaking partnership

This is sponsored content issued on behalf of Voyageur Pharmaceuticals, please see full disclaimer here.

" Medical supply company makes preliminary list for Russell 2000 and 3000 indexes

Quipt Home Medical, a medical supply company, has made the preliminary list to join the Russell 2000 and 3000 indexes.
MindBio Therapeutics - Chief Executive, Justin Hanka.

" Psychedelics stock moving forward with pioneering LSD clinical trial

Psychedelics stock MindBio Therapeutics receives ethics approval for its Phase 2a take-home LSD microdosing clinical trial.

" BriaCell closes $4M strategic investment

BriaCell Therapeutics (TSX:BCT) completed a previously-announced strategic investment by Prevail Partners.

" WELL Health expands primary care network in Alberta

WELL Health has acquired five primary care clinics from MCI Onehealth Technologies.

" Optimi’s psilocybe harvest is ready for Australia

Optimi Health (CSE: OPTI) has completed its harvest of psilocybe cubensis earmarked for export to Australia.

" PharmAla Biotech hits milestone with authorization for MDMA

PharmAla Biotech Holdings (MDMA) receives approval for a number of is LaNeo MDMA capsules to a Canadian physician.

" PharmaCielo (TSXV:PCLO) to ship pharmaceutical grade cannabis extract to South Africa

PharmaCielo (PCLO) has made an initial shipment of CBD Isolate to a specialty biotechnology company based in South Africa.